Effect of orlistat in overweight or obese patients with treated but inadequately controlled diastolic hypertension

被引：0

作者：

Bakris, G

Calhoun, D

Egan, B

Hellmann, C

Kingma, I

机构：

[1] Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA

[2] Univ Alabama, Birmingham, AL USA

[3] Med Univ S Carolina, Charleston, SC 29425 USA

[4] Roche Labs Inc, Nutley, NJ USA

来源：

OBESITY RESEARCH | 2001年 / 9卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：188S / 188S

页数：1

共 50 条

[21] Clinical efficacy of orlistat therapy in overweight and obese patients with insulin-treated type 2 diabetes - A 1-year randomized controlled trial
Kelley, DE
Bray, GA
Pi-Sunyer, FX
Klein, S
Hill, J
Miles, J
Hollander, P
DIABETES CARE, 2002, 25 (06) : 1033 - 1041
[22] Effect of orlistat on post-prandial glucose levels in overweight or obese patients with type 2 diabetes
Hanefeld, M
DIABETES, 2002, 51 : A99 - A100
[23] Economic evaluation of orlistat in overweight and obese patients with type 2 diabetes mellitus
Maetzel, A
Rouf, J
Covington, M
Wolf, A
PHARMACOECONOMICS, 2003, 21 (07) : 501 - 512
[24] THE EFFECT OF MODIFIED SHAM FEEDING WITH ORLISTAT IN OVERWEIGHT AND OBESE SUBJECTS: A PILOT STUDY
Dubin, R. L.
Fusiler, K.
Greenway, F.
JOURNAL OF INVESTIGATIVE MEDICINE, 2013, 61 (02) : 397 - 397
[25] Economic Evaluation of Orlistat in Overweight and Obese Patients with Type 2 Diabetes Mellitus
Andreas Maetzel
Jörg Ruof
Melva Covington
Anne Wolf
PharmacoEconomics, 2003, 21 : 501 - 512
[26] Effect of orlistat in obese patients with binge eating disorder
Golay, A
Laurent-Jaccard, A
Habicht, F
Gachoud, JP
Chabloz, M
Kammer, A
Schutz, Y
OBESITY RESEARCH, 2005, 13 (10): : 1701 - 1708
[27] Effect of orlistat, micronised fenofibrate and their combination on metabolic parameters in overweight and obese patients with the metabolic syndrome: the FenOrli study
Filippatos, TD
Kiortsis, DN
Liberopoulos, EN
Georgoula, M
Mikhailidis, DP
Elisaf, MS
CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (12) : 1997 - 2006
[28] Effect of orlistat on the need for concomitant anti-diabetic medication in overweight and obese patients with type 2 diabetes
Miles, JM
Halpern, A
DIABETES, 2002, 51 : A475 - A475
[29] Effect of orlistat on glycemic control and body weight in overweight or obese South African patients with type 2 diabetes
Bonnici, F
DIABETES, 2002, 51 : A412 - A413
[30] Orlistat reduces both anthropometric and analytic parameters in obese patients or patients with overweight type II
Lobon Hernandez, Ja
INTERNATIONAL JOURNAL OF OBESITY, 2007, 31 : S171 - S171

← 1 2 3 4 5 →